Management tracks: ISA, ImCheck, ArQule

Immunotherapy company ISA Pharmaceuticals B.V. (Leiden, the Netherlands) promoted CBO Gerben Moolhuizen to CEO, effective June 1. He succeeds CEO Ronald Loggers. Also in May, ISA hired Leon Hooftman as CMO. Hooftman was CMO at Allecra Therapeutics GmbH (Lörrach, Germany).

Immunomodulatory antibody company ImCheck Therapeutics S.A.S. (Marseille, France) appointed Debasish Roychowdhury as chairman. He is CMO at Partner Therapeutics Inc. (Boston, Mass.)...